Fresenius Medical Care

Big news! Fresenius Medical Care has been ranked #1 in gender diversity by manager magazin and Boston Consulting Group (BCG) – up 28 spots from last year! Hearty congratulations as well to our CEO Helen Giza, one of five female CEOs honored among the ‘100 Most Influential Women in the German Economy.’ Joining Helen on that top 100 list is also Katarzyna Mazur-Hofsäß, CEO of our MedTech segment Care Enablement. Kudos to Team FME for their work driving the value and importance of diversity in everything we do, and congrats again to Helen and Katarzyna for their individual honors. #Top100Frauen #Diversity #ProudToBeFME

Happiest of Holidays from all of us at Fresenius Medical Care! As we celebrate this festive season, we wish you and your loved ones’ warmth, peace, and boundless joy. May your holidays shine brightly, and may the New Year bring health, happiness, and prosperity to all. Thank you for being a part of our journey, and we are looking forward to seeing you in the new year! 💙✨ #SeasonsGreetings #HappyHolidays #TogetherAhead

News 📢: We are proud to announce that Fresenius Medical Care will return to the DAX 40 as of December 27th, 2024! Being part of Germany’s leading stock market index is truly an honor, and we are happy to enter the holiday season with such good news. Read more in today’s press release below.   Quote, CEO Helen Giza: “We are delighted to return to the DAX 40. In Germany and worldwide, the index is synonymous with German innovative strength and entrepreneurial growth. This recognition underscores the continuous hard work of our employees for our patients and shareholders and is a strong testament of our performance. Our path had been defined always very clearly to return to the large-cap index by turning around the performance and by successfully executing our strategy. We have delivered what we promised, and we are very happy to be back.”   Today’s press release can be found here: https://lnkd.in/dMqE3npF   #PressRelease #News #DAX40 #ProudToBeFME

At Fresenius Medical Care, respecting human rights and acting with integrity are not just aspirations; they are fundamental to who we are and what we do. Protecting these rights is a responsibility that belongs to all of us. Through robust processes, we actively identify, prevent, and address risks – supporting the well-being of the patients we serve, our employees, their communities, workers in the supply chain and stakeholders worldwide. Together, we contribute to upholding the fundamentals of human rights with our commitment to high-quality patient care, striving for a healthier future built on respect and dignity for all. Learn more about our commitment to human rights via the link: https://lnkd.in/eRM76Twf #HumanRightsDay #ProudToBeFME

Congratulations and thank you to our CEO and Management Board Chair Helen Giza for her outstanding leadership of Fresenius Medical Care! Today is Helen’s second anniversary as CEO, and we have made tremendous progress under her leadership.   As CEO, Helen wears many hats. But her core focus never wavers: Her commitment to our patients and her determination to see them live their best lives.     Helen is a determined and decisive leader whose heart is visible to everyone she encounters. Today we hold her up as a best-in-class example of true servant leadership.   Thank you, Helen, and Happy Anniversary!   #ProudToBeFME

I’m excited to celebrate my first International Day of Persons with Disabilities at Fresenius Medical Care – a day dedicated to honoring and embracing the spectrum of abilities that enrich our communities and workplaces. This is an opportunity to reflect on the incredible resilience and success of individuals with disabilities, including the stories shared by our own colleagues. Their experiences not only raise awareness of the challenges they face but also inspire us to foster greater understanding and build a stronger, more inclusive community. While International Day of Persons with Disabilities is celebrated once a year, creating a culture in which everyone feels they belong is a commitment we must uphold every day. Together, we can break down misconceptions, challenge stereotypes, and ensure everyone feels supported and valued. How will you contribute to building inclusive communities and workplaces every day? I encourage you to share your perspective below so we can learn from each other. #Belonging #DEI #EmployeeEngagement #ProudToBeFME #TogetherAhead

Did you know that people with diabetes don’t have to cut out carbs entirely? Balanced nutrition, including carbohydrates like whole grains, is key. Fiber is an important nutrient for you as it reduces the absorption of sugar. 🌾🌿 This World Diabetes Day, experts at FME debunk five common myths in the video below! 👉 Watch the full video for truths about living well – physically and mentally – with diabetes and diabetic kidney disease. 🍲 Bonus: Check out our delicious collection of diabetes and kidney-friendly recipes to support your journey: https://lnkd.in/evJ8Y4xn #DiabetesLife #DiabetesAwareness #KidneyHealth

With an aging population and rising rates of obesity and diabetes, the global landscape of chronic kidney disease is evolving. Because of that, Fresenius Medical Care’s team uses science-based modeling tools, grounded in public health data, to project trends and help better understand the needs of tomorrow’s patients. Watch now the latest episode of GMO Dialogues, where Dr. Doris H. Fuertinger, Head of Computational Medicine at Fresenius Medical Care, dives into how epidemiological models can help predict the future characteristics of kidney disease populations. https://lnkd.in/dgQUrt6D #GMODialogues #KidneyHealth #FutureOfHealthcare #ForOurPatients

Welcome to the team, Dr. Angela Kölbl! #Announcement #ProudToBeFME

News📢: Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024. Check out the Q3 earnings information we released today via the press release below. We delivered organic revenue growth of +2 % this quarter supported by both segments, Care Enablement and Care Delivery. Dialysis treatment volume growth turned positive in the U.S. market in Q3. The #FME25 transformation program achieved EUR 64 million additional sustainable savings by the end of Q3. With this continued momentum, we accomplished EUR 173 million additional sustainable savings year-to-date – well ahead of our savings goals for the year 2024. Quote CEO, Helen Giza: “In the third quarter, we continued the improvement of our financial performance, reporting meaningful progress in operating income margin towards our 2025 margin targets. The Care Delivery margin extended well into the 2025 margin target band while Care Enablement maintained the significant margin progress realized in the first half year. A very important milestone was the underlying U.S. same market treatment growth turning positive. In light of the developments in the first nine months, we confirm our revenue growth outlook and have tightened our outlook for operating income growth towards the upper end of the previous range with 16-18% for 2024.” Read more in today’s press release: https://lnkd.in/djwNqw7a   #Reporting #EarningsRelease #QuarterlyReport #Q32024 #InvestorRelations #ProudToBeFME